Literature DB >> 7195159

Anesthetic potencies and the unitary theory of narcosis.

J E Deady, D D Koblin, E I Eger, J E Heavner, B D'Aoust.   

Abstract

Anesthetic potencies of nitrous oxide, isoflurane, enflurane, halothane, cyclopropane, or chloroform were measured in male (CD-1) mice using three end points: (a) the ability to maintain an upright position (the righting-response ED50, RR ED50); (b) the response to a tail-clamp stimulus (MAC); and (c) the response to heat applied to the tail (tail-flick ED50, TF ED50). The ratio of RR ED50 to MAC ranged from mean values of 0.475 for isoflurane, 0.507 for cyclopropane, 0.524 for enflurane, and less than 0.55 for N2O, to 0.600 for halothane and 0.621 for chloroform. The ratios of RR EDS50 to MAC for halothane differed significantly from the ratios for isoflurane and enflurane. The mean values for TF ED50/MAC and RR ED50/TG ED50 ranged from 0.688 to 1.01 and 0.664 to 0.682, respectively, for isoflurane, enflurane, and halothane. The nitrous oxide RR ED50/TF ED50, however, was 1.34. The ratios of TF ED50 to MAC were significantly different for halothane and isoflurane. The different end points were measured in an attempt to determine whether the response in mice anesthetized with a particular agent was the same with varying stimuli. The differences found suggest that a unitary mechanism of anesthetic action cannot completely explain the depression defined by these three end points.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7195159

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  14 in total

1.  Modulation of human 5-hydroxytryptamine type 3AB receptors by volatile anesthetics and n-alcohols.

Authors:  Renna Stevens; Dirk Rüsch; Ken Solt; Douglas E Raines; Paul A Davies
Journal:  J Pharmacol Exp Ther       Date:  2005-04-14       Impact factor: 4.030

2.  Anaesthetic potencies of primary alkanols: implications for the molecular dimensions of the anaesthetic site.

Authors:  J K Alifimoff; L L Firestone; K W Miller
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

3.  7-Nitroindazole, a selective inhibitor of neuronal nitric oxide synthase: effect on sevoflurane MAC and cerebellar cyclic GMP in mice.

Authors:  Wei-Dong Mi; Fumito Ichinose; Takahisa Goto; Yoshinari Niimi; Masanori Uchiyama; Shigeho Morita
Journal:  J Anesth       Date:  1998-09       Impact factor: 2.078

4.  Variable effects of nitrous oxide at multiple levels of the central nervous system in goats.

Authors:  J F Antognini; X G Chen; M Sudo; S Sudo; E Carstens
Journal:  Vet Res Commun       Date:  2001-10       Impact factor: 2.459

5.  Role of caveolin-3 and glucose transporter-4 in isoflurane-induced delayed cardiac protection.

Authors:  Yasuo M Tsutsumi; Yoshitaka Kawaraguchi; Yousuke T Horikawa; Ingrid R Niesman; Michael W Kidd; Blake Chin-Lee; Brian P Head; Piyush M Patel; David M Roth; Hemal H Patel
Journal:  Anesthesiology       Date:  2010-05       Impact factor: 7.892

6.  Xenon and other volatile anesthetics change domain structure in model lipid raft membranes.

Authors:  Michael Weinrich; David L Worcester
Journal:  J Phys Chem B       Date:  2013-12-06       Impact factor: 2.991

7.  Nitrous oxide and isoflurane are synergistic with respect to amplitude and latency effects on sensory evoked potentials.

Authors:  Tod Sloan; H Sloan; J Rogers
Journal:  J Clin Monit Comput       Date:  2010-01-09       Impact factor: 2.502

8.  Focal heat stimulation for the determination of the minimum alveolar concentration of halothane in the rabbit.

Authors:  A T Sobair; D F Cottrell; M A Camburn
Journal:  Vet Res Commun       Date:  1997-04       Impact factor: 2.459

Review 9.  Is a new paradigm needed to explain how inhaled anesthetics produce immobility?

Authors:  Edmond I Eger; Douglas E Raines; Steven L Shafer; Hugh C Hemmings; James M Sonner
Journal:  Anesth Analg       Date:  2008-09       Impact factor: 5.108

10.  Caveolin-3 expression and caveolae are required for isoflurane-induced cardiac protection from hypoxia and ischemia/reperfusion injury.

Authors:  Yousuke T Horikawa; Hemal H Patel; Yasuo M Tsutsumi; Michelle M Jennings; Michael W Kidd; Yasuko Hagiwara; Yoshihiro Ishikawa; Paul A Insel; David M Roth
Journal:  J Mol Cell Cardiol       Date:  2007-10-11       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.